DOMH - Dominari Holdings Inc.
2.98
-0.060 -2.013%
Share volume: 36,201
Last Updated: 03-06-2026
Trading/Security And Commodity Brokers, Dealers, Exchanges & Services:
1.69%
PREVIOUS CLOSE
CHG
CHG%
$3.04
-0.06
-0.02%
Fundamental analysis
43%
Profitability
35%
Dept financing
21%
Liquidity
68%
Performance
50%
Performance
5 Days
-1.65%
1 Month
-18.13%
3 Months
-22.19%
6 Months
-51.07%
1 Year
-51.70%
2 Year
40.57%
Key data
Stock price
$2.98
DAY RANGE
$2.96 - $3.06
52 WEEK RANGE
$2.85 - $8.40
52 WEEK CHANGE
-$46.31
DIVIDEND
$0.32
EX-DIVIDEND DATE
02-24-2025
NEXT EARNINGS DATE
04-29-2025
Company detail
CEO: Anthony C. Hayes
Region: US
Website: aikidopharma.com
Employees: 4
IPO year: 2006
Issue type: Common Stock
Market: XNAS
Industry: Trading/Security And Commodity Brokers, Dealers, Exchanges & Services
Sector: Finance, Insurance, And Real Estate
Region: US
Website: aikidopharma.com
Employees: 4
IPO year: 2006
Issue type: Common Stock
Market: XNAS
Industry: Trading/Security And Commodity Brokers, Dealers, Exchanges & Services
Sector: Finance, Insurance, And Real Estate
AIkido Pharma Inc. focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses.
Recent news